MORGAN STANLEY - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$21,115,000
+64.8%
488,642
+61.2%
0.01%
+100.0%
Q2 2015$12,812,000
+182.6%
303,168
+159.3%
0.00%
+100.0%
Q1 2015$4,534,000
+3.0%
116,897
-10.6%
0.00%0.0%
Q4 2014$4,404,000
-51.2%
130,810
-49.2%
0.00%
-33.3%
Q3 2014$9,017,000
+35.0%
257,468
+26.7%
0.00%0.0%
Q2 2014$6,677,000
-45.3%
203,190
-38.6%
0.00%
-40.0%
Q1 2014$12,204,000
+171.4%
331,082
+182.6%
0.01%
+150.0%
Q4 2013$4,496,000
+69.7%
117,170
+21.2%
0.00%
+100.0%
Q3 2013$2,649,000
+27.2%
96,700
-2.5%
0.00%0.0%
Q2 2013$2,083,00099,1530.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders